Prescribing summary cards

Read our Guidelines prescribing summary cards to support your best-practice prescribing of specific medicines. Items may contain pharmaceutical promotional information.

DuoResp Spiromax (budesonide:formoterol) prescribing summary card

DuoResp® Spiromax® (budesonide/formoterol)

Commissioned by Teva UK Limited

This promotional prescribing summary card has been developed from content provided by Teva UK Limited. Information intended for UK healthcare professionals only.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Teva UK Limited on 0207 540 7117 or medinfo@tevauk.com.

Click here for prescribing information and adverse event reporting

DUOR-GB-00117
Date of preparation: March 2022

Soolantra prescribing summary card_Index image

Soolantra® (ivermectin) 10 mg/g cream

Commissioned by Galderma UK Ltd

This prescribing summary card was developed from content provided by Galderma UK Ltd. Information intended for UK healthcare professionals only. 
View Soolantra® (ivermectin) 10 mg/g cream prescribing and adverse event reporting information.
UKI-SOC-2100031 September 2021